The “Net Innovation Trend” and What It Means for Big Pharmas, Biotechs, and Generics
By Mark P. Mathieu
Innovation is the key value driver in healthcare. Over the past 8 years, the pharmaceuticals sector has lost a stunning $593 billion (-65%) in market cap while the two sectors with innovation – biotech and med tech – have each added $71 billion (+46%) and $19 billion (+6%) in market cap, respectively. Read More
|
|
More Big Pharma Research Cuts
Feb 08
|
Reuters | AstraZeneca, GlaxoSmithKline, and Pfizer all made cuts to R&D budgets and teams last week in an effort to trim research efforts that aren't delivering. But that's still not a proven antidote for what ails Big Pharma.
more
U.S. Scientists Given Access to Cloud Computing by Microsoft
Feb 05
|
New York Times | Microsoft and the National Science Foundation have agreed to offer American scientific researchers free access to the company’s new cloud computing service. A goal of the three-year project is to give scientists the computing power to cope with exploding amounts of research data.
more
Crowdsourcing Diabetes
Feb 05
|
Wired | The Harvard Clinical and Translational Science Center and InnoCentive are launching a series of Web-based innovation challenges aimed at harnessing Web 2.0 and crowdsourcing for the academic public healthcare community.
more
MORE NEWS BELOW
DNA Methylation Could Change Gene Expression
Feb 03
|
Bio-IT World | SINGAPORE—Researchers at the Genome Institute of Singapore and The Scripps Research Institute have shown dramatic changes in DNA methylation as stem cells differentiate and the patterns revealed could influence transcription and gene expression. The results were published today in Genome Research.
more
John Crowley Relives His Extraordinary Measures to Combat Pompe Disease
Feb 03
|
Bio-IT World | Biotech entrepreneur John Crowley, whose astonishing personal quest to develop a treatment for Pompe disease is captured in the new Harrison Ford movie Extraordinary Measures, spoke movingly about his family’s experiences and hopes in the opening keynote at CHI’s Molecular Medicine Tri-Conference (MMTC).
more
 | StorNext 4.0: Technical Product Brief
Proven in the world’s most data intensive industries, Quantum StorNext is a scalable, high-performance file system which allows data sharing across Linux, Mac, Unix, and Windows operating systems and manages data in enterprise storage environments. In this Technical Brief you'll learn: - How a high-performing file system can accelerate your business
- How to simplify your data management
- How a tiered storage approach can save you money
|  | Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense As a bio-technology or life sciences organization, your formulas, treatments and research and discoveries are the “lifeblood” of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing IP ownership, revenue and consequently your business if you can't prove time-of-creation and data authenticity. Learn how you can implement simple, cost-effective and automated controls to protect your scientific intellectual property. Consider: IP protection requirements in bio-pharma and other science-oriented industries can extend out 20, 30, 40 or more years Most electronic lab management solutions include generic authenticity controls, so how "legally defensible" is yours? Only standards-compliant, independent controls can future-proof your approach to long-term IP integrity protection and authenticity. Learn more - get the free whitepaper now
|  | The Key to Life Sciences Data Management: Transparent Migration Life sciences organizations face new data management challenges as the volume of research data grows and more data is kept online for longer times. Read this paper to learn about: - The benefits of transparent data migration (TDM)
- How TDM technologies can simplify data management.
- How using TDM can help increase storage utilization, improve computational workflow performance, and optimize the use of storage resources.
|
 Next-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe
This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe’s LiveCycle® Enterprise Suite. I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:
Creating faster and more efficient trial processes Reducing investigator burden Real-time sponsor transparency into study information Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR Download now.
 |
Innovative management in clinical trials
|
 |
Leaders in quality training resources
|
 |
Reports evaluating issues in pharmaceutical technology, business, and therapeutic markets
|
|
|
Feb 8, 2010
| Bio-IT World |
FULL STORIES
- Therapeutic Tax Credit to help small biotechs pay for research?
- AB SCIEX launches new company dedicated to life science analytical technologies
- Finland invests in European biomedical research infrastructures
- Infosys Technologies will design and implement the Research Informatics System at Elan Pharmaceuticals
- IBM has signed an agreement to acquire Initiate Systems
- GSK purchases lung disease drug from Apeiron Biologics
- Teva buts heads with Amgen
- RainDance Technologies appoints Sirshendu Roopom Banerjee as President and CEO
Bio-IT Weekly Update
eCliniqua
Pharma Services News
Employers -- Don't miss this opportunity to reach well-qualified life science candidates.
|